160 related articles for article (PubMed ID: 36001113)
21. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
22. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
23. miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.
Hu B; Mao Z; Du Q; Jiang X; Wang Z; Xiao Z; Zhu D; Wang X; Zhu Y; Wang H
Brain Res Bull; 2019 Jul; 149():21-31. PubMed ID: 30946881
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
25. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
26. Notch4-dependent antagonism of canonical TGF-β1 signaling defines unique temporal fluctuations of SMAD3 activity in sheared proximal tubular epithelial cells.
Grabias BM; Konstantopoulos K
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F123-33. PubMed ID: 23576639
[TBL] [Abstract][Full Text] [Related]
27. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
Jin Z; Gu C; Tian F; Jia Z; Yang J
Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
[TBL] [Abstract][Full Text] [Related]
28. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
[TBL] [Abstract][Full Text] [Related]
29. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
30. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
[TBL] [Abstract][Full Text] [Related]
31. Umbelliferone Ameliorates CCl
Mahmoud AM; Hozayen WG; Hasan IH; Shaban E; Bin-Jumah M
Inflammation; 2019 Jun; 42(3):1103-1116. PubMed ID: 30741365
[TBL] [Abstract][Full Text] [Related]
32. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
33. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells.
Zhang M; Fraser D; Phillips A
Am J Pathol; 2006 Oct; 169(4):1282-93. PubMed ID: 17003485
[TBL] [Abstract][Full Text] [Related]
34. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
35. TGF-β1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro.
Zhang Q; Chang X; Wang H; Liu Y; Wang X; Wu M; Zhan H; Li S; Sun Y
Environ Toxicol; 2020 Apr; 35(4):419-429. PubMed ID: 31737983
[TBL] [Abstract][Full Text] [Related]
36. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
37. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
38. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3.
Tian F; Zhang ZY; Sun J; Han YC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):787-794. PubMed ID: 33577033
[TBL] [Abstract][Full Text] [Related]
39. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation.
Sferra R; Vetuschi A; Catitti V; Ammanniti S; Pompili S; Melideo D; Frieri G; Gaudio E; Latella G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1484-98. PubMed ID: 23111960
[TBL] [Abstract][Full Text] [Related]
40. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
